GALERA THERAPEUTICS, INC.

Profile

Company Names

GALERA THERAPEUTICS, INC.

Addresses

45 LIBERTY BOULEVARD, SUITE 230, MALVERN, PA 19355

2 WEST LIBERTY BOULEVARD, SUITE 110, MALVERN, PA 19355

101 LINDENWOOD DRIVE, SUITE 405, MALVERN, PA 19355

Phone Numbers

610-725-1500

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$140,912,918.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2024-12-30 
$2,885,000.00 
$2,885,000.00 
$0.00 
Equity 
5
2018-08-30 
$70,185,418.00 
$70,185,418.00 
$0.00 
Equity 
4
2016-11-15 
$15,000,000.00 
$15,000,000.00 
$0.00 
Equity 
3
2015-10-01 
$37,102,500.00 
$37,102,500.00 
$0.00 
Equity 
2
2014-07-28 
$4,740,000.00 
$9,480,000.00 
$4,740,000.00 
Equity 
1
2012-11-26 
$11,000,000.00 
$11,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LAWRENCE 
 
ALLEVA 
DIRECTOR
GALERA THERAPEUTICS, INC.
JAMES 
 
BARRETT 
DIRECTOR
PREDICTIVE BIOSCIENCES, INC   |  CARDIOXYL PHARMACEUTICALS INC   |  PHASEBIO PHARMACEUTICALS INC   |  AMICUS THERAPEUTICS INC   |  HOMETOWN FINANCIAL GROUP INC   |  BLEND BIOSCIENCES, INC.   |  BLEND THERAPEUTICS, INC.   |  AGENEBIO, INC.   |  ZP HOLDINGS INC   |  LOXO ONCOLOGY, INC.   |  NEXIMMUNE, INC.   |  GALERA THERAPEUTICS, INC.   |  TARVEDA THERAPEUTICS, INC.   |  EDGE TOTAL INTELLIGENCE INC.   |  ABSURD SNACKS - LIGHTHOUSE NETWORK VENTURES, LLC
ROBERT 
 
BEARDSLEY 
EXECUTIVE OFFICER, DIRECTOR
KEMPHARM INC   |  CONFLUENCE LIFE SCIENCES, INC.   |  GALERA THERAPEUTICS, INC.   |  EPIGENETX, LLC   |  PINEWOOD PARK INVESTORS, LLC   |  LSC SOLANO, LLC   |  LSC HOLLISTER, LLC   |  CIRIUS THERAPEUTICS, INC.
ROBERT 
A. 
BEARDSLEY 
EXECUTIVE OFFICER, DIRECTOR
GALERA THERAPEUTICS LLC   |  EUCLISES PHARMACEUTICALS, INC.   |  GALERA THERAPEUTICS, INC.
ROBERT 
J. 
CALCATERRA 
DIRECTOR
CARDIALEN, INC.   |  EUCLISES PHARMACEUTICALS, INC.   |  GALERA THERAPEUTICS, INC.
NANCY 
T. 
CHANG 
DIRECTOR
APPLIED OPTOELECTRONICS INC   |  GALERA THERAPEUTICS, INC.
THOMAS 
 
DYRBERG 
DIRECTOR
LUX BIOSCIENCES INC   |  GLOUCESTER PHARMACEUTICALS INC   |  OPHTHOTECH CORP.   |  ALLOCURE INC   |  PANOPTICA, INC.   |  GALERA THERAPEUTICS, INC.   |  PRAXIS PRECISION MEDICINES, INC.
ARTHUR 
 
FRATAMICO 
EXECUTIVE OFFICER
FLEXION THERAPEUTICS INC   |  GALERA THERAPEUTICS, INC.   |  RADIANT BIOTHERAPEUTICS INC.
MICHAEL 
R. 
FRIEDMAN 
DIRECTOR
GALERA THERAPEUTICS, INC.
ERIC 
 
GULVE 
DIRECTOR
GALERA THERAPEUTICS LLC   |  GALERA THERAPEUTICS, INC.   |  CARDIALEN, INC.
JON 
T. 
HOLMLUND 
EXECUTIVE OFFICER
GALERA THERAPEUTICS, INC.
JEFFERY 
L. 
KEENE 
EXECUTIVE OFFICER
GALERA THERAPEUTICS, INC.
KEVIN 
 
LOKAY 
DIRECTOR
GALERA THERAPEUTICS, INC.
CAMPBELL 
 
MURRAY 
DIRECTOR
ALIOS BIOPHARMA INC   |  TOKAI PHARMACEUTICALS INC   |  AILERON THERAPEUTICS INC   |  BIORELIX INC   |  EUTHYMICS BIOSCIENCE INC   |  AKEBIA THERAPEUTICS, INC.   |  AERPIO THERAPEUTICS, INC.   |  NEUROVANCE, INC.   |  EBI LIFE SCIENCES, INC.   |  IMAGINAB, INC.   |  GALERA THERAPEUTICS, INC.   |  BIONANO GENOMICS, INC   |  EUTHYMICS BIOSCIENCE, INC.   |  ICEBREAKER HEALTH, INC.   |  ANNEXON, INC.   |  TSCAN THERAPEUTICS, INC.   |  RENOVACOR, INC.   |  LIGHTHOUSE PHARMACEUTICALS, INC.
MICHAEL 
 
POWELL 
DIRECTOR
ALVINE PHARMACEUTICALS INC   |  TRIUS THERAPEUTICS INC   |  ASCENTA THERAPEUTICS, INC.   |  ARCHIPELAGO LEARNING, INC.   |  OBJECTVIDEO INC   |  EXCELLENT ENERGY SOLUTIONS, LLC   |  SOFINNOVA VENTURE PARTNERS VIII, L.P.   |  MIRNA THERAPEUTICS, INC.   |  SUPPLY VISION, INC.   |  PASSPORT SYSTEMS INC   |  CATALYST BIOSCIENCES INC   |  CHIGWELL LTD   |  MERCURY MEDIA SCIENCE B LTD   |  CHECKMATE PHARMACEUTICALS, INC.   |  DAUNTLESS 1, INC.   |  DAUNTLESS 2, INC.   |  E-CIRCUIT MOTORS, INC.   |  PIONYR IMMUNOTHERAPEUTICS, INC.   |  TM TECHNOLOGIES INC   |  GALERA THERAPEUTICS, INC.   |  SYNLOGIC, INC.   |  AEOVIAN PHARMACEUTICALS, INC.
DENNIS 
P. 
RILEY 
EXECUTIVE OFFICER
GALERA THERAPEUTICS, INC.
STEPHEN 
 
ROSS 
EXECUTIVE OFFICER
DATAMINR, INC.   |  MONARCH COMMUNITY BANCORP INC   |  COMPOUND HOLDINGS I, LLC   |  COLUMBUS OFFICE REIT I, INC.   |  RJA PUTWRITE SELECT FUND LP   |  GALERA THERAPEUTICS, INC.   |  2021 PERMIAN BASIN JV, GP
MICHAL 
 
SILVERBERG 
DIRECTOR
GALERA THERAPEUTICS, INC.   |  TWENTYEIGHT-SEVEN, INC.   |  ADICET BIO, INC.   |  IMMPACT BIO USA INC.   |  REDONA THERAPEUTICS, INC.   |  FORE US BIO INC.   |  CAPSTAN THERAPEUTICS, INC.   |  ONL THERAPEUTICS, INC.   |  AVERNA THERAPEUTICS INC.
HENRY 
 
SKINNER 
DIRECTOR
AVILA THERAPEUTICS INC   |  THESAN PHARMACEUTICALS, INC.   |  AEGLEA BIOTHERAPEUTICS HOLDINGS, LLC   |  GALERA THERAPEUTICS, INC.   |  AEGLEA BIOTHERAPEUTICS, INC.   |  PROTEOSTASIS THERAPEUTICS, INC.   |  MACROLIDE PHARMACEUTICALS, INC.   |  CAVION, INC.   |  NEUROVIA, INC.   |  GENOMEDX INC.   |  CURASEN THERAPEUTICS, INC.   |  DECIPHER BIOSCIENCES, INC.
J. 
MEL 
SORENSEN 
EXECUTIVE OFFICER, DIRECTOR
GALERA THERAPEUTICS, INC.   |  ONCOPIA THERAPEUTICS, LLC
MEL 
 
SORENSEN 
EXECUTIVE OFFICER, DIRECTOR
GALERA THERAPEUTICS, INC.
JOEL 
 
SUSSMAN 
EXECUTIVE OFFICER
ASCENTA THERAPEUTICS, INC.   |  PHASEBIO PHARMACEUTICALS INC   |  COMBINENT BIOMEDICAL SYSTEMS, INC.   |  GALERA THERAPEUTICS, INC.   |  IMMUNOME INC.
FRANK 
 
TORTI 
DIRECTOR
CERECOR INC.   |  GALERA THERAPEUTICS, INC.   |  TARVEDA THERAPEUTICS, INC.   |  ORPHOMED, INC.   |  EARGO, INC.   |  XOC PHARMACEUTICALS, INC.   |  EARLENS CORP   |  ARBUTUS BIOPHARMA CORP   |  IMMUNOVANT, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-01-14
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-12-30 
2025-01-13
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-12-30 
2018-09-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-30 
2016-11-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-15 
2015-10-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-01 
2014-08-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-07-28 
2012-12-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-11-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#